Prediction of Response to Pegylated Interferon plus Ribavirin by IL28B Gene Variation in Patients Coinfected with HIV and Hepatitis C Virus

被引:117
作者
Pineda, Juan A. [1 ]
Caruz, Antonio [2 ,3 ]
Rivero, Antonio [5 ]
Neukam, Karin [1 ]
Salas, Irene [3 ]
Camacho, Angela [5 ]
Palomares, Jose C. [2 ]
Mira, Jose A. [1 ]
Martinez, Antonio [4 ]
Roldan, Carmen [1 ]
de la Torre, Julian [5 ]
Macias, Juan [1 ]
机构
[1] Hosp Univ Valme, Infect Dis Unit, Seville 41014, Spain
[2] Hosp Univ Valme, Microbiol Unit, Seville 41014, Spain
[3] Univ Jaen, Fac Sci, Immunogenet Unit, Jaen, Spain
[4] Hosp Univ Reina Sofia, Unit Clin Anal, Mol Genet Lab, Cordoba, Spain
[5] Hosp Univ Reina Sofia, Infect Dis Unit, Cordoba, Spain
关键词
LIPOPROTEIN CHOLESTEROL LEVELS; INSULIN-RESISTANCE; THERAPY; RECEPTOR; ASSOCIATION; GENOTYPE; ALPHA;
D O I
10.1086/656235
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Variation in the IL28B gene is associated with sustained virologic response (SVR) to pegylated interferon plus ribavirin in hepatitis C virus (HCV)-monoinfected patients with genotype 1. Data on other genotypes and on patients coinfected with human immunodeficiency virus (HIV) and HCV are more limited. We aimed to assess the predictive ability of variations in the single-nucleotide polymorphism rs12979860 for SVR in HIV/HCV-coinfected patients, regardless of HCV genotype. Methods. The rs12979860 genotype was determined by polymerase chain reaction in 154 patients who had received therapy against HCV with pegylated interferon plus ribavirin. Results. rs12979860 genotype was TT in 20 patients (13%), TC in 66 patients (43%), and CC in 68 patients (44%). Rates of SVR in patients with genotype CC and in those with genotype TC or TT, according to HCV genotype, were, respectively, 50% and 17% (P<.001) in patients with genotype 1, 80% and 25% (P = .027) in patients with genotype 4, and 93% and 77% (P = .115) in patients with genotype 3. The median (interquartile range) low-density lipoprotein cholesterol level in patients with rs12979860 CC was 89 mg/dL (73-120 mg/dL) versus 75 mg/dL (55-91 mg/dL) (P = .001) in those with TC or TT. Independent predictors of SVR were HCV genotype 2-3 (odds ratio [OR], 13.98; 95% confidence interval [CI], 4.87-40.1; P<.001), rs12979860 CC (OR, 5.05; 95% CI, 2.04-12.5; P<.001), baseline plasma HCV RNA load of <= 600,000 IU/mL (OR, 1.99; 95% CI, 1.18 3.34; P = .009), and female sex (OR, 4.28; 95% CI, 1.08-16.96; P = .039). Conclusions. IL28B gene variations independently predict SVR in HIV/HCV-coinfected patients with HCV genotype 1 and non-genotype 1 HCV infection. The association between rs12979860 and plasma low-density lipoprotein cholesterol suggests that the system low-density lipoprotein ligand/receptor might be involved in the effect of this genotype.
引用
收藏
页码:788 / 795
页数:8
相关论文
共 27 条
[1]   Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor [J].
Agnello, V ;
Abel, G ;
Elfahal, M ;
Knight, GB ;
Zhang, QX .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) :12766-12771
[2]   Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels [J].
Akuta, Norio ;
Suzuki, Fumitaka ;
Kawamura, Yusuke ;
Yatsuji, Hiromi ;
Sezaki, Hitomi ;
Suzuki, Yoshiyuki ;
Hosaka, Tetsuya ;
Kobayashi, Masahiro ;
Kobayashi, Mariko ;
Arase, Yasuji ;
Ikeda, Kenji ;
Kumada, Hiromitsu .
JOURNAL OF HEPATOLOGY, 2007, 46 (03) :403-410
[3]   Haploview: analysis and visualization of LD and haplotype maps [J].
Barrett, JC ;
Fry, B ;
Maller, J ;
Daly, MJ .
BIOINFORMATICS, 2005, 21 (02) :263-265
[4]   Insulin resistance impairs sustained virological response rate to pegylated interferon plus ribavirin in HIV-hepatitis C virus-coinfected patients: HOMAVIC-ANRS HC02 Study [J].
Cacoub, Patrice ;
Carrat, Fabrice ;
Bedossa, Pierre ;
Lambert, Jerome ;
Penaranda, Guillaume ;
Pol, Stanislas ;
Halfon, Philippe .
ANTIVIRAL THERAPY, 2009, 14 (06) :839-845
[5]   Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy [J].
D'Souza, R ;
Sabin, CA ;
Foster, GR .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (07) :1509-1515
[6]   Baseline serum low-density lipoprotein cholesterol levels predict response to hepatitis C virus therapy in HIV/hepatitis C virus coinfected patients [J].
del Valle, Jose ;
Mira, Jose A. ;
de los Santos, Ignacio ;
Lopez-Cortes, Luis F. ;
Merino, Dolores ;
Rivero, Antonio ;
Giron, Jose A. ;
Rios-Villegas, Maria J. ;
Gonzalez-Serrano, Mercedes ;
Collado, Antonio ;
Garcia-Garcia, Jose A. ;
Pineda, Juan A. .
AIDS, 2008, 22 (08) :923-930
[7]   Human interferon-λ3 is a potent member of the type III interferon family [J].
Dellgren, C. ;
Gad, H. H. ;
Hamming, O. J. ;
Melchjorsen, J. ;
Hartmann, R. .
GENES AND IMMUNITY, 2009, 10 (02) :125-131
[8]  
Enjoji M, 2000, Med Sci Monit, V6, P841
[9]   AN ANTIVIRAL SOLUBLE FORM OF THE LDL RECEPTOR-INDUCED BY INTERFERON [J].
FISCHER, DG ;
TAL, N ;
NOVICK, D ;
BARAK, S ;
RUBINSTEIN, M .
SCIENCE, 1993, 262 (5131) :250-253
[10]   Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance [J].
Ge, Dongliang ;
Fellay, Jacques ;
Thompson, Alexander J. ;
Simon, Jason S. ;
Shianna, Kevin V. ;
Urban, Thomas J. ;
Heinzen, Erin L. ;
Qiu, Ping ;
Bertelsen, Arthur H. ;
Muir, Andrew J. ;
Sulkowski, Mark ;
McHutchison, John G. ;
Goldstein, David B. .
NATURE, 2009, 461 (7262) :399-401